Abstract
INTRODUCTION: The objective of this study is to estimate the budgetary impact of the adoption of lixisenatide in combination with insulin glargine (iGlarLixi) for the treatment of type II diabetes mellitus from the perspective of the Guatemalan Social Security Institute (IGSS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
